Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of a credit agreement with Needham Bank, a Massachusetts-based commercial bank, ...
Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodiesComplete blockade of TL1A binding to DR3 for over 3 months expected at doses of 1 mg/ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results